BCL2 antisense transcripts decrease intracellular Bcl2 expression and sensitize LNCaP prostate cancer cells to apoptosis-inducing agents.

Source:http://linkedlifedata.com/resource/pubmed/id/11776759

Download in:

View as

General Info

PMID
11776759